American Healthcare REIT ("AHR") Announces Fourth Quarter 2024 and Full Year 2024 Results; Issues Full Year 2025 Guidance

, /PRNewswire/ -- American Healthcare REIT, Inc. (the "Company," "we," "our," "management," or "us") (NYSE: AHR) announced today its fourth quarter and full year 2024 results and is issuing full year 2025 guidance. Key Highlights: Reported GAAP net loss attributable to controlling interest of $(31.8) million and GAAP net loss attributable to common stockholders of $(0.21) per diluted share for the three months ended December 31, 2024. Reported GAAP net loss attributable to controlling interest of $(37.8) million and GAAP net loss attributable to common stockholders of $(0.29) per diluted share for the year ended December 31, 2024. Reported Normalized Funds from Operations attributable to common stockholders ("NFFO") of $0.40 and $1.41 per diluted share for the three months and year ended December 31, 2024, respectively. Achieved total portfolio Same-Store Net Operating Income ("NOI") growth of 21.6% and 17.7% for the three months and year ended December 31, 2024, respectively, compared to the same periods in 2023. Achieved 66.6% and 28.0% Same-Store NOI growth during the three months ended December 31, 2024, from its senior housing operating properties ("SHOP") and integrated senior health campuses ("ISHC"), respectively, compared to the same period in 2023. Achieved 52.8% and 23.8% Same-Store NOI growth during the year ended December 31, 2024, from its SHOP and ISHC segments, respectively, compared to the same period in 2023. During the year ended December 31, 2024, the Company purchased over $650 million of new investments. During the three months ended December 31, 2024, the Company acquired a SHOP asset in the Atlanta MSA for a total consideration of approximately $7.5 million, before closing and transaction costs. In November, the Company established an at-the-market equity offering program ("ATM program") allowing the Company to sell shares of common stock for aggregate gross proceeds of up to $500 million. During the three months ended December 31, 2024, the Company issued 4,285,531 shares of common stock from its ATM program, raising gross proceeds of approximately $120.2 million. During the year ended December 31, 2024, the Company raised total gross proceeds of approximately $1.36 billion through its equity offerings and ATM program. The Company is issuing total portfolio Same-Store NOI growth guidance of 7.0% to 10.0% and NFFO per diluted share guidance of $1.56 to $1.60 for the year ending December 31, 2025. Reported a 4.2x improvement in the Company's Net Debt-to-Annualized Adjusted EBITDA from 8.5x as of December 31, 2023, to 4.3x as of December 31, 2024. "We have much to be proud of in AHR's first year as a listed Healthcare REIT," said Danny Prosky, the Company's President and Chief Executive Officer. "We delivered strong earnings and achieved attractive NOI growth across our diversified healthcare portfolio. As we look ahead to 2025, the supply and demand fundamentals within the healthcare real estate industry remain robust. AHR is steadfast in its commitment to delivering high-quality care and performance across our facilities. This year, we expect to deliver both solid earnings per share and Same-Store NOI growth, building on the successful year we had in 2024." Fourth Quarter 2024 and Full-Year 2024 Results The Company's Same-Store NOI growth results for the three months and year ended December 31, 2024, are detailed below. Same-Store NOI growth results from its managed portfolio, comprised of ISHC and SHOP segments, led the Company's growth in 2024, compared to 2023, supported by occupancy growth and NOI margin expansion over the course of the year. Three Months Ended December 31, 2024 Relative to Three Months Ended December 31, 2023 Segment Same-Store NOI Growth ISHC 28.0 % Outpatient Medical 1.3 % SHOP 66.6 % Triple-Net Leased Properties 1.7 % Total Portfolio 21.6 % Year Ended December 31, 2024 Relative to Year Ended December 31, 2023 Segment Same-Store NOI Growth ISHC 23.8 % Outpatient Medical 0.5 % SHOP 52.8 % Triple-Net Leased Properties 3.2 % Total Portfolio 17.7 % "Our portfolio focus on senior housing investments proved to be a winning strategy as senior housing fueled strong total portfolio Same-Store NOI growth in 2024," said Gabe Willhite, the Company's Chief Operating Officer. "Our ISHC and SHOP segments once again produced exceptional results in the fourth quarter with 28.0% and 66.6% year-over-year Same-Store NOI growth, respectively. I believe deeply that partnering with a highly-curated list of operating partners in combination with our ability to provide more focused asset management support, continue to be key differentiators driving our performance and demonstrating the strength of our platform. In 2025, we expect continued growth driven by strong senior housing fundamentals, which we anticipate to produce outsized revenue growth opportunities relative to expense growth and sustained margin expansion." Transactional Activity As previously announced, on October 1, 2024, the Company acquired a SHOP asset located in the Atlanta MSA consisting of 90 units for approximately $7.5 million, before closing and transaction costs, reflecting a price per unit of approximately $83,750. Operations at the property were transitioned to Senior Solutions Management Group, one of the Company's existing regional operators, in a RIDEA structure. Subsequent to quarter end, the Company is under contract to acquire two SHOP assets for approximately $70.5 million. The transactions are expected to close in the first half of 2025. Both SHOP properties are expected to be operated by two of the Company's existing regional operators. Additionally, the Company also completed a lease buyout within its ISHC segment for approximately $15.9 million. During the year ended December 31, 2024, the Company purchased over $650 million of new investments, including the minority membership interest in Trilogy Holdings that had been held by a joint venture partner. The Company has approved new ISHC development projects, including new campuses, independent living villas, and campus and wing expansions that will begin construction in 2025, with total expected construction costs of approximately $136.6 million. As previously announced, on October 16, 2024, the Company sold one Outpatient Medical building for approximately $19.4 million. Additionally, during the three months ended December 31, 2024, the Company sold 10 properties from its Outpatient Medical, Triple-Net Leased Properties and ISHC segments for approximately $120.5 million. During the year ended December 31, 2024, the Company sold approximately $155.5 million of properties from various segments, further refining its portfolio and using proceeds to pay down debt or allocate capital to better risk-adjusted return opportunities, such as SHOP acquisitions and ISHC development. Subsequent to quarter end, the Company sold one SHOP property for approximately $3.3 million. Capital Markets and Balance Sheet Activity As of December 31, 2024, the Company's total consolidated indebtedness was $1.69 billion, and it had approximately $984.3 million of total liquidity, comprised of cash, restricted cash and undrawn capacity on its lines of credit. The Company's Net-Debt-to-Annualized Adjusted EBITDA as of December 31, 2024, was 4.3x. During the three months ended December 31, 2024, the Company established an ATM equity offering program, pursuant to which it may, from time to time, offer and sell shares of common stock for aggregate gross proceeds of up to $500 million. During the three months ended December 31, 2024, the Company issued 4,285,531 shares of common stock through its ATM program for gross proceeds of approximately $120.2 million, at an average price of $28.05 per share. As of December 31, 2024, the remaining amount available under the ATM program for future sales of common stock was approximately $379.8 million. "Our guidance reflects our expectation that 2025 will be another year of strong earnings growth, building on the excellent double-digit Same-Store NOI growth delivered in 2024," said Brian Peay, the Company's Chief Financial Officer. "Additionally, we were able to strategically raise additional equity at attractive pricing and utilize those proceeds to buy out the remainder of Trilogy and also dramatically improve our balance sheet. I am very proud of the team's efforts this year, creating capacity to allow us to continue to execute on our business plan while ending the year with Net Debt-to- Annualized Adjusted EBITDA of 4.3x." Full Year 2025 Guidance The Company is issuing guidance for the year ending December 31, 2025. The Company's 2025 guidance does not assume any additional transaction or capital markets activity beyond the items disclosed in this earnings release. Guidance ranges are detailed below: Full Year 2025 Guidance Full Year 2024 Results Metric Midpoint FY 2025 Range Net income (loss) per diluted share $0.28 $0.26 to $0.30 $(0.29) NAREIT FFO per diluted share $1.51 $1.49 to $1.53 $1.26 NFFO per diluted share $1.58 $1.56 to $1.60 $1.41 Total Portfolio SS NOI Growth 8.5 % 7.0% to 10.0% 17.7 % Segment-Level SS NOI Growth / (Decline): ISHC 11.0 % 10.0% to 12.0% 23.8 % Outpatient Medical 0.0 % (1.0%) to 1.0% 0.5 % SHOP 20.0 % 18.0% to 22.0% 52.8 % Triple-Net Leased Properties (1.0 %) (1.5%) to (0.5%) 3.2 % Certain of the assumptions underlying the Company's 2025 guidance can be found within the Non-GAAP reconciliations in this earnings release and in the appendix of the Company's Fourth Quarter 2024 Supplemental Financial Information ("Supplemental"). A reconciliation of net income (loss) calculated in accordance with GAAP to NAREIT FFO and NFFO can be found within the Non-GAAP reconciliations in this earnings release. Non-GAAP financial measures and other terms, as used in this earnings release, are also defined and further explained in the Supplemental. The Company is unable to provide without reasonable effort guidance for the most comparable GAAP financial measures of total revenues and property operating and maintenance expenses. Additionally, a reconciliation of the forward-looking Non-GAAP financial measures of Same-Store NOI growth to the comparable GAAP financial measures cannot be provided without unreasonable effort because the Company is unable to reasonably predict certain items contained in the GAAP measures, including non-recurring and infrequent items that are not indicative of the Company's ongoing operations. Such items include, but are not limited to, impairment on depreciated real estate assets, net gain or loss on sale of real estate assets, stock-based compensation, casualty loss, non-Same-Store revenues and non-Same-Store operating expenses. These items are uncertain, depend on various factors and could have a material impact on the Company's GAAP results for the guidance period. Distributions As previously announced, the Company's Board of Directors declared a cash distribution for the quarter ended December 31, 2024 of $0.25 per share of its common stock. The fourth quarter distribution was paid in cash on January 17, 2025, to stockholders of record as of December 31, 2024. Supplemental Information The Company has disclosed supplemental information regarding its portfolio, financial position and results of operations as of, and for the three months ended, December 31, 2024, and certain other information, which is available on the Investor Relations section of the Company's website at https://ir.americanhealthcarereit.com. Conference Call and Webcast Information The Company will host a webcast and conference call at 1:00 p.m. Eastern Time on February 28, 2025. During the conference call, Company executives will review fourth quarter 2024 results, provide additional comments on its 2025 guidance, discuss recent events and conduct a question-and-answer period. To join via webcast, investors may use the following link: https://events.q4inc.com/attendee/718447410. To join the live telephone conference call, please dial one of the following numbers at least five minutes prior to the start time: North America - Toll-Free: (800) 715-9871International Toll: +1 (646) 307-1963Conference ID: 2930459 A digital replay of the call will be available on the Investor Relations section of the Company's website at https://ir.americanhealthcarereit.com shortly after the conclusion of the call. Forward-Looking Statements Certain statements contained in this press release, including statements relating to the Company's expectations regarding its interest expense savings, balance sheet, net income or loss per diluted share, FFO per diluted share, NFFO per diluted share, total portfolio Same-Store NOI growth, segment-level Same-Store NOI growth or decline, occupancy, NOI growth, revenue growth, margin expansion, purchases and sales of assets, construction plans, and plans for Trilogy may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may," "will," "can," "expect," "intend," "anticipate," "estimate," "believe," "continue," "possible," "initiatives," "focus," "seek," "objective," "goal," "strategy," "plan," "potential," "potentially," "preparing," "projected," "future," "long-term," "once," "should," "could," "would," "might," "uncertainty" or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Any such forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which the Company operates, and beliefs of, and assumptions made by, the Company's management and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied therein, including, without limitation, risks disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, expected to be filed on February 28, 2025, and other periodic reports filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statements contained in this release. Non-GAAP Financial Measures The Company's reported results are presented in accordance with GAAP. The Company also discloses the following Non-GAAP financial measures: EBITDA, Adjusted EBITDA, Net Debt-to-Annualized Adjusted EBITDA, NAREIT FFO, NFFO, NOI and Same-Store NOI. The Company believes these Non-GAAP financial measures are useful supplemental measures of its operating performance and used by investors and analysts to compare the operating performance of the Company between periods and to other REITs or companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items. Definitions of the Non-GAAP financial measures used herein and reconciliations to the most directly comparable financial measure calculated in accordance with GAAP can be found at the end of this earnings release. See below for further information regarding the Company's Non-GAAP financial measures. EBITDA and Adjusted EBITDA Management uses earnings before interest, taxes, depreciation and amortization ("EBITDA") and Adjusted EBITDA to facilitate internal and external comparisons to our historical operating results and in making operating decisions. EBITDA and Adjusted EBITDA are widely used by investors, lenders, credit and equity analysts in the valuation, comparison, and investment recommendations of companies. Additionally, EBITDA and Adjusted EBITDA are utilized by our Board of Directors to evaluate management. Neither EBITDA nor Adjusted EBITDA represents net income (loss) or cash flows provided from operating activities as determined in accordance with GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the EBITDA and Adjusted EBITDA may not be comparable to similarly entitled items reported by other REITs or other companies. In addition, management uses Net Debt-to-Annualized Adjusted EBITDA as a measure of our ability to service our debt. Funds from Operations (FFO) and Normalized Funds from Operations (NFFO) We believe that the use of FFO, which excludes the impact of real estate-related depreciation and amortization and impairments, provides a further understanding of our operating performance to investors, industry analysts and our management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses and interest costs, which may not be immediately apparent from net income (loss). However, FFO and NFFO should not be construed to be (i) more relevant or accurate than the current GAAP methodology in calculating net income (loss) as an indicator of our operating performance, (ii) more relevant or accurate than GAAP cash flows from operations as an indicator of our liquidity or (iii) indicative of funds available to fund our cash needs, including our ability to make distributions to our stockholders. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the Non-GAAP FFO and NFFO measures and the adjustments to GAAP in calculating FFO and NFFO. Presentation of this information is intended to provide useful information to investors, industry analysts and management as they compare the operating performance metrics used by the REIT industry, although it should be noted that some REITs may use different methods of calculating funds from operations and normalized funds from operations, so comparisons with such REITs may not be meaningful. Net Operating Income We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are appropriate supplemental performance measures to reflect the performance of our operating assets because NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI exclude certain items that are not associated with the operations of the properties. We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are widely accepted measures of comparative operating performance in the real estate community and is useful to investors in understanding the profitability and operating performance of our property portfolio. However, our use of the terms NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are not equivalent to our net income (loss) as determined under GAAP and may not be a useful measure in measuring operational income or cash flows. Furthermore, NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be considered as alternatives to net income (loss) as an indication of our operating performance or as an alternative to cash flows from operations as an indication of our liquidity. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be construed to be more relevant or accurate than the GAAP methodology in calculating net income (loss). NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should be reviewed in conjunction with other measurements as an indication of our performance. About American Healthcare REIT, Inc. American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing, and outpatient medical buildings across the United States, the United Kingdom and the Isle of Man. AMERICAN HEALTHCARE REIT, INC. CONSOLIDATED BALANCE SHEETS As of December 31, 2024 and 2023 (In thousands, except share and per share amounts) (Unaudited) December 31, 2024 2023 ASSETS Real estate investments, net $ 3,366,648 $ 3,425,438 Debt security investment, net 91,264 86,935 Cash and cash equivalents 76,702 43,445 Restricted cash 46,599 47,337 Accounts and other receivables, net 211,104 185,379 Identified intangible assets, net 161,473 180,470 Goodwill 234,942 234,942 Operating lease right-of-use assets, net 163,987 227,846 Other assets, net 135,338 146,141 Total assets $ 4,488,057 $ 4,577,933 LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY Liabilities: Mortgage loans payable, net $ 982,071 $ 1,302,396 Lines of credit and term loan, net 688,534 1,223,967 Accounts payable and accrued liabilities 258,324 242,905 Identified intangible liabilities, net 3,001 6,095 Financing obligations 34,870 41,756 Operating lease liabilities 165,239 225,502 Security deposits, prepaid rent and other liabilities 51,856 76,134 Total liabilities 2,183,895 3,118,755 Commitments and contingencies Redeemable noncontrolling interests 220 33,843 Equity: Stockholders' equity: Preferred stock, $0.01 par value per share; 200,000,000 shares authorized; none issued and outstanding — — Common Stock, $0.01 par value per share; 700,000,000 shares authorized; 157,446,697 shares issued and outstanding as of December 31, 2024 and none issued and outstanding as of December 31, 2023 1,564 — Class T common stock, $0.01 par value per share; 200,000,000 shares authorized; none issued and outstanding as of December 31, 2024 and 19,552,856 shares issued and outstanding as of December 31, 2023 — 194 Class I common stock, $0.01 par value per share; 100,000,000 shares authorized; none issued and outstanding as of December 31, 2024 and 46,673,320 shares issued and outstanding as of December 31, 2023 — 467 Additional paid-in capital 3,720,268 2,548,307 Accumulated deficit (1,458,089) (1,276,222) Accumulated other comprehensive loss (2,512) (2,425) Total stockholders' equity 2,261,231 1,270,321 Noncontrolling interests 42,711 155,014 Total equity 2,303,942 1,425,335 Total liabilities, redeemable noncontrolling interests and equity $ 4,488,057 $ 4,577,933 AMERICAN HEALTHCARE REIT, INC. CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS For the Three Months Ended and Years Ended December 31, 2024 and 2023 (In thousands, except share and per share amounts) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 Revenues and grant income: Resident fees and services $ 496,833 $ 433,284 $ 1,883,798 $ 1,668,742 Real estate revenue 45,907 49,267 186,870 190,401 Grant income — 30 — 7,475 Total revenues and grant income 542,740 482,581 2,070,668 1,866,618 Expenses: Property operating expenses 430,572 385,012 1,653,893 1,502,310 Rental expenses 13,039 13,053 53,239 57,475 General and administrative 12,064 11,341 47,559 47,510 Business acquisition expenses 807 3,551 7,141 5,795 Depreciation and amortization 46,915 43,960 179,192 182,604 Total expenses 503,397 456,917 1,941,024 1,795,694 Other income (expense): Interest expense: Interest expense (including amortization of deferred financing costs, debt discount/premium and loss on debt and derivative extinguishments) (30,301) (41,185) (127,730) (163,191) Gain (loss) in fair value of derivative financial instruments 3,192 (9,126) 1,030 (926) Gain on dispositions of real estate investments, net 2,956 2,695 5,213 32,472 Impairment of real estate investments (45,755) (1,389) (45,755) (13,899) Impairment of intangible assets — (10,520) — (10,520) Loss from unconsolidated entities (2,505) (794) (6,868) (1,718) Gain on re-measurement of previously held equity interest — — — 726 Foreign currency (loss) gain (3,119) 1,935 (774) 2,307 Other income, net 4,246 1,649 11,353 7,601 Total net other expense (71,286) (56,735) (163,531) (147,148) Loss before income taxes (31,943) (31,071) (33,887) (76,224) Income tax (expense) benefit (486) 112 (1,713) (663) Net loss (32,429) (30,959) (35,600) (76,887) Net loss (income) attributable to noncontrolling interests 656 3,534 (2,212) 5,418 Net loss attributable to controlling interest $ (31,773) $ (27,425) $ (37,812) $ (71,469) Net loss per share of Common Stock, Class T common stock and Class I common stock attributable to controlling interest: Basic $ (0.21) $ (0.42) $ (0.29) $ (1.08) Diluted $ (0.21) $ (0.42) $ (0.29) $ (1.08) Weighted average number of shares of Common Stock, Class T common stock and Class I common stock outstanding: Basic 153,702,650 66,079,343 130,637,539 66,047,114 Diluted 153,702,650 66,079,343 130,637,539 66,047,114 Net loss $ (32,429) $ (30,959) $ (35,600) $ (76,887) Other comprehensive (loss) income: Foreign currency translation adjustments (359) 199 (87) 265 Total other comprehensive (loss) income (359) 199 (87) 265 Comprehensive loss (32,788) (30,760) (35,687) (76,622) Comprehensive loss (income) attributable to noncontrolling interests 656 3,534 (2,212) 5,418 Comprehensive loss attributable to controlling interest $ (32,132) $ (27,226) $ (37,899) $ (71,204) AMERICAN HEALTHCARE REIT, INC. FFO and Normalized FFO Reconciliation For the Three Months Ended and Years Ended December 31, 2024 and 2023 (In thousands, except share and per share amounts) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 Net loss $ (32,429) $ (30,959) $ (35,600) $ (76,887) Depreciation and amortization related to real estate — consolidated properties 46,877 43,922 179,040 182,452 Depreciation and amortization related to real estate — unconsolidated entities 504 147 1,186 401 Impairment of real estate investments — consolidated properties 45,755 1,389 45,755 13,899 Gain on dispositions of real estate investments, net — consolidated properties (2,956) (2,695) (5,213) (32,472) Net loss (income) attributable to noncontrolling interests 656 3,534 (2,212) 5,418 Gain on re-measurement of previously held equity interest — — — (726) Depreciation, amortization, impairments, net gain/loss on dispositions and gain on re-measurement — noncontrolling interests (1,986) (6,846) (17,851) (26,518) NAREIT FFO attributable to controlling interest $ 56,421 $ 8,492 $ 165,105 $ 65,567 Business acquisition expenses $ 807 $ 3,551 $ 7,141 $ 5,795 Amortization of above- and below-market leases 415 (2,489) 1,692 9,744 Amortization of closing costs — debt security investment 86 74 324 278 Change in deferred rent (668) (89) (2,411) 1,149 Non-cash impact of changes to equity instruments 2,037 1,377 9,367 5,621 Capitalized interest (73) (36) (334) (163) Loss on debt and derivative extinguishments 3,530 — 5,382 345 (Gain) loss in fair value of derivative financial instruments (3,192) 9,126 (1,030) 926 Foreign currency loss (gain) 3,119 (1,935) 774 (2,307) Impairment of intangible assets — 10,520 — 10,520 Adjustments for unconsolidated entities (1) 38 (320) (321) Adjustments for noncontrolling interests (85) (3,810) (768) (4,786) Normalized FFO attributable to controlling interest $ 62,396 $ 24,819 $ 184,922 $ 92,368 NAREIT FFO and Normalized FFO weighted average common shares outstanding — diluted 154,449,288 66,079,343 131,211,731 66,047,114 NAREIT FFO per common share attributable to controlling interest — diluted $ 0.37 $ 0.13 $ 1.26 $ 0.99 Normalized FFO per common share attributable to controlling interest — diluted $ 0.40 $ 0.38 $ 1.41 $ 1.40 AMERICAN HEALTHCARE REIT, INC. Adjusted EBITDA Reconciliation For the Three Months Ended December 31, 2024 (In thousands) (Unaudited) Net loss $ (32,429) Interest expense (including amortization of deferred financing costs, debt discount/premium and loss on debt extinguishments) 30,301 Income tax expense 486 Depreciation and amortization (including amortization of leased assets and accretion of lease liabilities) 47,376 EBITDA $ 45,734 Loss from unconsolidated entities 2,505 Straight line rent and amortization of above/below market leases (714) Non-cash impact of changes to equity instruments 2,037 Business acquisition expenses 807 Gain on dispositions of real estate investments, net (2,956) Amortization of closing cost - debt security investment 86 Foreign currency loss 3,119 Gain in fair value of derivative financial instruments (3,192) Impairment of real estate investments 45,755 Non-recurring one-time items (2,024) Adjusted EBITDA $ 91,157 AMERICAN HEALTHCARE REIT, INC. NOI and Cash NOI Reconciliation For the Three Months Ended and Years Ended December 31, 2024 and 2023 (In thousands) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 Net loss $ (32,429) $ (30,959) $ (35,600) $ (76,887) General and administrative 12,064 11,341 47,559 47,510 Business acquisition expenses 807 3,551 7,141 5,795 Depreciation and amortization 46,915 43,960 179,192 182,604 Interest expense 30,301 41,185 127,730 163,191 (Gain) loss in fair value of derivative financial instruments (3,192) 9,126 (1,030) 926 Gain on dispositions of real estate investments, net (2,956) (2,695) (5,213) (32,472) Impairment of real estate investments 45,755 1,389 45,755 13,899 Impairment of intangible assets — 10,520 — 10,520 Loss from unconsolidated entities 2,505 794 6,868 1,718 Gain on re-measurement of previously held equity interest — — — (726) Foreign currency loss (gain) 3,119 (1,935) 774 (2,307) Other income, net (4,246) (1,649) (11,353) (7,601) Income tax expense (benefit) 486 (112) 1,713 663 Net operating income $ 99,129 $ 84,516 $ 363,536 $ 306,833 Grant Income — (30) — (7,475) Total NOI (excluding Grant Income) $ 99,129 $ 84,486 $ 363,536 $ 299,358 Straight line rent (672) (584) (3,234) (3,481) Facility rental expense 7,642 8,774 31,989 37,025 Other non-cash adjustments 158 (2,397) 1,187 9,946 COVID subsidies — — — (171) Cash NOI from dispositions (2,508) — (2,508) — Cash NOI attributable to noncontrolling interests(1) (271) (242) (1,016) (895) Cash NOI $ 103,478 $ 90,037 $ 389,954 $ 341,782 (1) All periods are based upon current quarter's ownership percentage. AMERICAN HEALTHCARE REIT, INC. Same-Store NOI Reconciliation For the Three Months Ended and Years Ended December 31, 2024 and 2023 (In thousands) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 ISHC NOI (excluding Grant Income) $ 53,586 $ 41,766 $ 189,273 $ 146,063 Facility rental expense 7,642 8,774 31,989 37,025 Cash NOI from dispositions (341) — (341) — Cash NOI (1) $ 60,887 $ 50,540 $ 220,921 $ 183,088 New acquisitions/dispositions/transitions/other (1) (6,266) (6,709) (24,153) (24,975) Non-Core Properties (1) (928) (460) (4,007) (160) Other normalizing adjustments (1) — (1,429) 974 (1,429) Same-Store NOI (1) $ 53,693 $ 41,942 $ 193,735 $ 156,524 Outpatient Medical NOI $ 20,800 $ 23,825 $ 83,855 $ 91,611 Straight line rent (134) (291) (568) (1,320) Other non-cash adjustments (81) (2,633) 252 (1,959) Cash NOI from dispositions (261) — (261) — Cash NOI (2) $ 20,324 $ 20,901 $ 83,278 $ 88,332 New acquisitions/dispositions/transitions — (802) (2,119) (7,664) Non-Core Properties (335) (373) (1,506) (1,406) Same-Store NOI (2) $ 19,989 $ 19,726 $ 79,653 $ 79,262 SHOP NOI $ 12,675 $ 6,506 $ 40,632 $ 20,369 Other non-cash adjustments — 11 — 5 COVID subsidies — — — (171) Cash NOI attributable to noncontrolling interests (2) (80) (56) (264) (158) Cash NOI $ 12,595 $ 6,461 $ 40,368 $ 20,045 New acquisitions/dispositions/transitions (3,236) (1,010) (7,256) 1,474 Development conversion 576 340 2,290 1,551 Other normalizing adjustments — 171 233 257 Same-Store NOI $ 9,935 $ 5,962 $ 35,635 $ 23,327 Triple-Net Leased Properties NOI $ 12,068 $ 12,389 $ 49,776 $ 41,315 Straight line rent (538) (293) (2,666) (2,161) Other non-cash adjustments 239 225 935 11,900 Cash NOI from dispositions (1,906) — (1,906) — Cash NOI attributable to noncontrolling interest (2) (191) (186) (752) (737) Cash NOI $ 9,672 $ 12,135 $ 45,387 $ 50,317 Debt security investment (2,117) (2,011) (8,690) (8,040) New acquisitions/dispositions/transitions — (2,708) (6,454) (12,996) Non-Core Properties (379) (359) (1,495) (1,413) Same-Store NOI $ 7,176 $ 7,057 $ 28,748 $ 27,868 AMERICAN HEALTHCARE REIT, INC. Same-Store NOI Reconciliation - (Continued) For the Three Months Ended and Years Ended December 31, 2024 and 2023 (In thousands) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 Total Portfolio NOI (excluding Grant Income) $ 99,129 $ 84,486 $ 363,536 $ 299,358 Straight line rent (672) (584) (3,234) (3,481) Facility rental expense 7,642 8,774 31,989 37,025 Other non-cash adjustments 158 (2,397) 1,187 9,946 COVID subsidies — — — (171) Cash NOI from dispositions (2,508) — (2,508) — Cash NOI attributable to noncontrolling interests (2) (271) (242) (1,016) (895) Cash NOI (1)(2) $ 103,478 $ 90,037 $ 389,954 $ 341,782 Debt security investment (2,117) (2,011) (8,690) (8,040) New acquisitions/dispositions/transitions/other (1) (9,502) (11,229) (39,982) (44,161) Development conversion 576 340 2,290 1,551 Non-Core Properties (1) (1,642) (1,192) (7,008) (2,979) Other normalizing adjustments (1) — (1,258) 1,207 (1,172) Same-Store NOI (1)(2) $ 90,793 $ 74,687 $ 337,771 $ 286,981 (1) Prior periods' information is presented to reflect the increase in ownership to 100% in the Company's ISHC segment effective September 2024. (2) All periods are based upon current quarter's ownership percentage. AMERICAN HEALTHCARE REIT, INC. Same-Store Revenue Reconciliation For the Three Months Ended and Years Ended December 31, 2024 and 2023 (In thousands) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 ISHC GAAP revenue and Grant Income $ 423,290 $ 384,993 $ 1,619,812 $ 1,489,355 Grant Income — (30) — (7,475) Cash revenue from dispositions (1,774) — (1,774) — Cash revenue (1) $ 421,516 $ 384,963 $ 1,618,038 $ 1,481,880 Revenue attributable to non-Same-Store properties (1) (128,772) (117,025) (491,479) (441,605) Revenue attributable to Non-Core Properties (1) (8,098) (6,926) (31,251) (25,237) Other normalizing revenue adjustments (1) — — (1,236) — Same-Store revenue (1) $ 284,646 $ 261,012 $ 1,094,072 $ 1,015,038 Outpatient Medical GAAP revenue $ 33,276 $ 36,257 $ 134,740 $ 146,068 Straight line rent (134) (291) (568) (1,320) Other non-cash adjustments (399) (2,995) (1,113) (3,349) Cash revenue from dispositions (304) — (304) — Cash revenue (2) $ 32,439 $ 32,971 $ 132,755 $ 141,399 Revenue attributable to non-Same-Store properties — (1,197) (3,029) (12,721) Revenue attributable to Non-Core Properties (479) (482) (2,004) (1,892) Same-Store revenue (2) $ 31,960 $ 31,292 $ 127,722 $ 126,786 SHOP GAAP revenue $ 73,543 $ 48,321 $ 263,986 $ 186,862 Cash revenue attributable to noncontrolling interests (2) (304) (271) (1,167) (1,287) Cash revenue $ 73,239 $ 48,050 $ 262,819 $ 185,575 Revenue attributable to non-Same-Store properties (27,955) (7,692) (86,922) (28,178) Revenue attributable to development conversion (491) (183) (1,587) (1,451) Same-Store revenue $ 44,793 $ 40,175 $ 174,310 $ 155,946 Triple-Net Leased Properties GAAP revenue $ 12,631 $ 13,010 $ 52,130 $ 44,333 Straight line rent (538) (293) (2,666) (2,161) Other non-cash adjustments 220 206 859 11,833 Cash revenue from dispositions (1,910) — (1,910) — Cash revenue attributable to noncontrolling interest (2) (190) (186) (752) (738) Cash revenue $ 10,213 $ 12,737 $ 47,661 $ 53,267 Debt security investment (2,117) (2,011) (8,690) (8,040) Revenue attributable to non-Same-Store properties — (2,757) (6,507) (13,662) Revenue attributable to Non-Core Properties (499) (445) (1,881) (1,802) Same-Store revenue $ 7,597 $ 7,524 $ 30,583 $ 29,763 AMERICAN HEALTHCARE REIT, INC. Same-Store Revenue Reconciliation - (Continued) For the Three Months Ended and Years Ended December 31, 2024 and 2023 (In thousands) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 Total Portfolio GAAP revenue and Grant Income $ 542,740 $ 482,581 $ 2,070,668 $ 1,866,618 Straight line rent (672) (584) (3,234) (3,481) Other non-cash adjustments (179) (2,789) (254) 8,484 Grant Income — (30) — (7,475) Cash revenue from dispositions (3,988) — (3,988) — Cash revenue attributable to noncontrolling interests (2) (494) (457) (1,919) (2,025) Cash revenue (1)(2) $ 537,407 $ 478,721 $ 2,061,273 $ 1,862,121 Debt security investment (2,117) (2,011) (8,690) (8,040) Revenue attributable to non-Same-Store properties (1) (156,727) (128,671) (587,937) (496,166) Revenue attributable to development conversion (491) (183) (1,587) (1,451) Revenue attributable to Non-Core Properties (1) (9,076) (7,853) (35,136) (28,931) Other normalizing revenue adjustments (1) — — (1,236) — Same-Store revenue (1)(2) $ 368,996 $ 340,003 $ 1,426,687 $ 1,327,533 (1) Prior periods' information is presented to reflect the increase in ownership to 100% in the Company's ISHC segment effective September 2024. (2) All periods are based upon current quarter's ownership percentage. AMERICAN HEALTHCARE REIT, INC. Earnings Guidance Reconciliation For the Year Ending December 31, 2025 (Dollars and shares in millions, except per share amounts) (Unaudited) Full Year2025 Guidance Low High Net income attributable to common stockholders $ 40.59 $ 46.71 Depreciation and amortization(1) 192.49 192.49 NAREIT FFO attributable to common stockholders $ 233.08 $ 239.20 Amortization of other intangible assets/liabilities(1) $ 1.89 $ 1.89 Change in deferred rent(1) (1.00) (1.00) Non-cash impact of changes to equity plan(1)(2) 8.96 8.96 Other adjustments(3) 1.26 1.26 Normalized FFO attributable to common stockholders $ 244.19 $ 250.31 Net income per common share — diluted $ 0.26 $ 0.30 NAREIT FFO per common share — diluted $ 1.49 $ 1.53 Normalized FFO per common share — diluted $ 1.56 $ 1.60 NAREIT FFO and Normalized FFO weighted average shares — diluted 156.4 156.4 Total Portfolio Same-Store NOI growth 7.0 % 10.0 % Segment-Level Same-Store NOI growth / (decline): ISHC 10.0 % 12.0 % Outpatient Medical (1.0 %) 1.0 % SHOP 18.0 % 22.0 % Triple-Net Leased Properties (1.5 %) (0.5 %) (1) Amounts presented net of noncontrolling interests' share and AHR's share of unconsolidated entities. (2) Amounts represent amortization of equity compensation and fair value adjustments to performance-based equity compensation. (3) Includes adjustments for capitalized interest, business acquisition expenses and additional items as noted in the Company's definition for NFFO. Definitions Adjusted EBITDA: EBITDA excluding the impact of gain or loss from unconsolidated entities, straight line rent and amortization of above/below market leases, non-cash stock-based compensation expense, business acquisition expenses, gain or loss on sales of real estate investments, unrealized foreign currency gain or loss, change in fair value of derivative financial instruments, impairments of real estate investments, impairments of intangible assets and goodwill, and non-recurring one-time items.Cash NOI: NOI excluding the impact of, without duplication, (1) non-cash items such as straight-line rent and the amortization of lease intangibles, (2) third-party facility rent payments and (3) other items set forth in the Cash NOI reconciliation included herein. Both Cash NOI and Same-Store NOI include Pro-Rata ownership and other adjustments.EBITDA: A Non-GAAP financial measure that is defined as earnings before interest, taxes, depreciation and amortization.GAAP revenue: Revenue recognized in accordance with Generally Accepted Accounting Principles ("GAAP"), which includes straight line rent and other non-cash adjustments.ISHC: Integrated senior health campuses include a range of senior care, including independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Integrated senior health campuses are operated utilizing a RIDEA structure.MSA: Metropolitan statistical area; a geographic area defined by the United States Office of Management and Budget that includes a city with at least 50,000 people and the surrounding counties with economic ties. MSAs are used to group cities and counties for statistical data and population censuses.NAREIT FFO or FFO: Funds from operations attributable to controlling interest; a Non-GAAP financial measure, consistent with the standards established by the White Paper on FFO approved by the Board of Governors of NAREIT (the "White Paper"). The White Paper defines FFO as net income (loss) computed in accordance with GAAP, excluding gains or losses from sales of certain real estate assets, gains or losses upon consolidation of a previously held equity interest, and impairment write-downs of certain real estate assets and investments, plus depreciation and amortization related to real estate, after adjustments for unconsolidated partnerships and joint ventures. While impairment charges are excluded from the calculation of FFO as described above, investors are cautioned that impairments are based on estimated future undiscounted cash flows. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO.Net Debt: Total long-term debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash related to debt.NOI: Net operating income; a Non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, business acquisition expenses, depreciation and amortization, interest expense, gain or loss in fair value of derivative financial instruments, gain or loss on dispositions, impairments of real estate investments, impairments of intangible assets and goodwill, income or loss from unconsolidated entities, gain on re-measurement of previously held equity interest, foreign currency gain or loss, other income or expense and income tax benefit or expense.Non-Core Properties: Assets that have been deemed not essential to generating future economic benefit or value to our day-to-day operations and/or are projected to be sold.Normalized FFO attributable to controlling interest or NFFO: FFO further adjusted for the following items included in the determination of GAAP net income (loss): expensed acquisition fees and costs, which we refer to as business acquisition expenses; amounts relating to changes in deferred rent and amortization of above and below-market leases (which are adjusted in order to reflect such payments from a GAAP accrual basis); the non-cash impact of changes to our equity instruments; non-cash or non-recurring income or expense; the noncash effect of income tax benefits or expenses; capitalized interest; impairments of intangible assets and goodwill; amortization of closing costs on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect Normalized FFO on the same basis.Occupancy: With respect to OM, the percentage of total rentable square feet leased and occupied, including month-to-month leases, as of the date reported. With respect to all other property types, occupancy represents average quarterly operating occupancy based on the most recent quarter of available data. The Company uses unaudited, periodic financial information provided solely by tenants to calculate occupancy and has not independently verified the information. Occupancy metrics are reflected at our Pro-Rata share.Outpatient Medical or OM: Outpatient Medical buildings.Pro-Rata: As of December 31, 2024, we owned and/or operated eight buildings through entities of which we owned between 90.0% and 98.0% of the ownership interests. Because we have a controlling interest in these entities, these entities and the properties these entities own are consolidated in our financial statements in accordance with GAAP. However, while such properties are presented in our financial statements on a consolidated basis, we are only entitled to our Pro-Rata share of the net cash flows generated by such properties. As a result, we have presented certain property information herein based on our Pro-Rata ownership interest in these entities and the properties these entities own, as of the applicable date, and not on a consolidated basis. In such instances, information is noted as being presented on a "Pro-Rata share" basis.RevPOR: Revenue per occupied room. RevPOR is calculated as total revenue generated by occupied rooms divided by the number of occupied rooms.RIDEA: Used to describe properties within the portfolio that utilize the RIDEA structure as described in "RIDEA structure".RIDEA structure: A structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, pursuant to which we lease certain healthcare real estate properties to a wholly-owned taxable REIT subsidiary ("TRS"), which in turn contracts with an eligible independent contractor ("EIK") to operate such properties for a fee. Under this structure, the EIK receives management fees, and the TRS receives revenue from the operation of the healthcare real estate properties and retains, as profit, any revenue remaining after payment of expenses (including intercompany rent paid to us and any taxes at the TRS level) necessary to operate the property. Through the RIDEA structure, in addition to receiving rental revenue from the TRS, we retain any after-tax profit from the operation of the healthcare real estate properties and benefit from any improved operational performance while bearing the risk of any decline in operating performance at the properties.Same-Store or SS: Properties owned or consolidated the full year in both comparison years and that are not otherwise excluded. Properties are excluded from Same-Store if they are: (1) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (2) impacted by materially disruptive events, such as flood or fire for an extensive period of time; or (3) scheduled to undergo or currently undergoing major expansions/renovations or business model transitions or have transitioned business models after the start of the prior comparison period.Same-Store NOI or SS NOI: Cash NOI for our Same-Store properties. Same-Store NOI is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. Both Cash NOI and Same-Store NOI include ownership and other adjustments.SHOP: Senior housing operating properties.Square Feet or Sq. Ft.: Net rentable square feet calculated utilizing Building Owners and Managers Association measurement standards.Total Debt: The principal balances of the Company's revolving credit facility, term loan and secured indebtedness as reported in the Company's consolidated financial statements.Trilogy: Trilogy Investors, LLC; one of our consolidated subsidiaries, in which we indirectly owned a 100% interest as of December 31, 2024.Trilogy REIT Holdings or Trilogy Holdings: Trilogy REIT Holdings, LLC, which indirectly owned a 100% interest in Trilogy as of December 31, 2024.Triple-net leased: A lease where the tenant is responsible for making rent payments, maintaining the leased property, and paying property taxes and other expenses. Contact: Alan PetersonEmail: [email protected] SOURCE American Healthcare REIT, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

American Healthcare REIT ("AHR") Announces Fourth Quarter 2024 and Full Year 2024 Results; Issues Full Year 2025 Guidance

FAQ

Why Bullish?

How important is it?

Why Long Term?

Related Companies

Related News